Bacterial membrane lipids in the action of antimicrobial agents

Journal of Peptide Science

Volumn 17, Issue 5, 2011, Pages 298-305

  Epand, Richard M ^a   Epand, Raquel F ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Antimicrobial peptide; Bacterial membrane; Membrane domain

Indexed keywords

AMPHOLYTE; ANTIINFECTIVE AGENT; MEMBRANE LIPID;

BACTERIAL MEMBRANE; CELL CYCLE ARREST; CELL DEATH; CELL MEMBRANE; GRAM NEGATIVE BACTERIUM; LIPID COMPOSITION; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; REVIEW;

ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; CELL MEMBRANE; MEMBRANE LIPIDS;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA;

EID: 79953790729     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1319     Document Type: Review

References (39)

1. Hornung V, Latz E. Intracellular DNA recognition. Nat. Rev. Immunol. 2010; 10: 123-130.
2. Joshi S, Bisht GS, Rawat DS, Kumar A, Kumar R, Maiti S, Pasha S. Interaction studies of novel cell selective antimicrobial peptides with model membranes and E. coli ATCC 11 775. Biochim. Biophys. Acta 2010; 1798: 1864-1875.
3. Shin S, Kim JK, Lee JY, Jung KW, Hwang JS, Lee J, Lee DG, Kim I, Shin SY, Kim Y. Design of potent 9-mer antimicrobial peptide analogs of protaetiamycine and investigation of mechanism of antimicrobial action. J. Pept. Sci. 2009; 15: 559-568.
4. Chen FY, Lee MT, Huang HW. Sigmoidal concentration dependence of antimicrobial peptide activities: a case study on alamethicin. Biophys. J. 2002; 82: 908-914.
5. Matsuzaki K. Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim. Biophys. Acta 1998; 1376: 391-400.
6. Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers 2002; 66: 236-248.
7. Yang L, Gordon VD, Mishra A, Som A, Purdy KR, Davis MA, Tew GN, Wong GCL. Synthetic antimicrobial oligomers induce acomposition-dependent topological transition in membranes. J. Am. Chem. Soc. 2007; 129: 12141-12147.
8. Epand RF, Sarig H, Mor A, Epand RM. Cell-wall interactions and the selective bacteriostatic activity of a miniature oligo-acyl-lysyl. Biophys. J. 2009; 97: 2250-2257.
9. Marchand C, Krajewski K, Lee HF, Antony S, Johnson AA, Amin R, Roller P, Kvaratskhelia M, Pommier Y. Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites. Nucleic Acids Res. 2006; 34: 5157-5165.
10. Breukink E, Wiedemann I, van Kraaij C, Kuipers OP, Sahl HG, de Kruijff B. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 1999; 286: 2361-2364.
11. Almeida PF, Pokorny A. Mechanisms of antimicrobial, cytolytic, and cell-penetrating peptides: from kinetics to thermodynamics. Biochemistry 2009; 48: 8083-8093.
12. Kates M, Syz JY, Gosser D, Haines TH. pH-dissociation characteristics of cardiolipin and its 2'-deoxy analogue. Lipids 1993; 28: 877-882.
13. Lewis RNAH, Zweytick D, Pabst G, Lohner K, McElhaney RN. Calorimetric, X-ray diffraction, and spectroscopic studies of the thermotropic phase behavior and organization of tetramyristoyl cardiolipin membranes. Biophys. J. 2007; 92: 3166-3177.
14. Epand RF, Wang G, Berno B, Epand RM. Lipid segregation explains selective toxicity of a series of fragments derived from the human cathelicidin LL-37. Antimicrob. Agents Chemother. 2009; 53: 3705-3714.
15. Epand RM, Rotem S, Mor A, Berno B, Epand RF. Bacterial membranes as predictors of antimicrobial potency. J. Am. Chem. Soc. 2008; 130: 14346-14352.
16. Jean-Francois F, Castano S, Desbat B, Odaert B, Roux M, Metz-Boutigue MH, Dufourc EJ. Aggregation of cateslytin beta-sheets on negatively charged lipids promotes rigid membrane domains: a new mode of action for antimicrobial peptides? Biochemistry 2008; 47: 6394-6402.
17. 2H-nuclear magnetic resonance. Biophys. J. 1989; 56: 1037-1041.
18. Arouri A, Dathe M, Blume A. Peptide induced demixing in PG/PE lipid mixtures: a mechanism for the specificity of antimicrobial peptides towards bacterial membranes? Biochim. Biophys. Acta 2009; 1788: 650-659.
19. van der Kraan M, van Marle J, Nazmi K, Groenink J, van't Hof W, Veerman ECI, Bolscher JGM, Amerongen AVN. Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli. Peptides 2005; 26: 1537-1542.
20. Sternberg B. Liposomes as a model for membrane structure and structural transformations: a liposome album. In Nonmedical Applications of Liposomes, Lasic DD, Barenholz Y (eds). CRC Press: Boca Raton, FL, 1996; 271-297.
21. Sternberg B. Freeze-fracture electron microscopy of liposomes. In Liposome Preparation and Related Techniques: Liposome Technology, Gregoriadis G (ed.). CRC Press: Boca Raton, FL, 1993; 363-383.
22. Epand RM, Epand RF, Arnusch CJ, Papahadjopoulos-Sternberg B, Wang G, Shai Y. Lipid clustering by three homologous arginine-rich antimicrobial peptides is insensitive to amino acid arrangement and induced secondary structure. Biochim. Biophys. Acta 2010; 1798: 1272-1280.
23. Oreopoulos J, Epand RF, Epand RM, Yip CM. Peptide-induced domain formation in supported lipid bilayers: direct evidence by combined atomic force and polarized total internal reflection fluorescence microscopy. Biophys. J. 2010; 98: 815-823.
24. Ratledge C, Wilkinson SG. Microbial Lipids, Vol. 1, Academic Press: London, 1988; 1-963.
25. Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, Kalbacher H, Nieuwenhuizen WF, Jung G, Tarkowski A, van Kessel KP, van Strijp JA. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J. Exp. Med. 2001; 193: 1067-1076.
26. Camargo IL, Neoh HM, Cui L, Hiramatsu K. Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype. Antimicrob. Agents Chemother. 2008; 52: 4289-4299.
27. Mishra NN, Yang SJ, Sawa A, Rubio A, Nast CC, Yeaman MR, Bayer AS. Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 2009; 53: 2312-2318.
28. Ernst CM, Staubitz P, Mishra NN, Yang SJ, Hornig G, Kalbacher H, Bayer AS, Kraus D, Peschel A. The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion. PLoS. Pathog. 2009; 5: e1000660.
29. Epand RF, Maloy WL, Ramamoorthy A, Epand RM. Probing the "Charge cluster mechanism" in amphipathic helical cationic antimicrobial peptides. Biochemistry 2010; 49: 4076-4084.
30. Lehrer RI, Barton A, Ganz T. Concurrent assessment of inner and outer membrane permeabilization and bacteriolysis in E. coli by multiple-wavelength spectrophotometry. J. Immunol. Methods 1988; 108: 153-158.
31. Epand RM, Epand RF. Domains in bacterial membranes and the action of antimicrobial agents. Mol. Biosyst. 2009; 5: 580-587.
32. Epand RM, Epand RF. Lipid domains in bacterial membranes and the action of antimicrobial agents. Biochim. Biophys. Acta 2009; 1788: 289-294.
33. Epand RM, Epand RF. Membrane properties and the design of peptides specifically targeting Gram negative bacteria. In Antimicrobial Peptides: Discovery, Design and Novel Therapeutic Strategies, Wang G (ed). CABI: Wallingford, 2011.
34. Li X, Li Y, Han H, Miller DW, Wang G. Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. J. Am. Chem. Soc. 2006; 128: 5776-5785.
35. Radzishevsky IS, Rotem S, Bourdetsky D, Navon-Venezia S, Carmeli Y, Mor A. Improved antimicrobial peptides based on acyl-lysine oligomers. Nat. Biotechnol. 2007; 25: 657-659.
36. Rotem S, Radzishevsky IS, Bourdetsky D, Navon-Venezia S, Carmeli Y, Mor A. Analogous oligo-acyl-lysines with distinct antibacterial mechanisms. FASEB J. 2008; 22: 2652-2661.
37. Matsumoto K, Kusaka J, Nishibori A, Hara H. Lipid domains in bacterial membranes. Mol. Microbiol. 2006; 61: 1110-1117.
38. Gould D. Effective strategies for prevention and control of Gram-negative infections. Nurs. Stand. 2009; 23: 42-46.
39. Maragakis LL. Recognition and prevention of multidrug-resistant Gram-negative bacteria in the intensive care unit. Crit. Care Med. 2010; 38: S345-S351.